2024-01-12 11:01:35 ET
More on Entheon Biomedical Corp., Nevro, etc.
- Regeneron Pharmaceuticals Inc. (REGN) 42nd Annual JPMorgan Healthcare Conference - (Transcript)
- Why I Expect Regeneron To Keep Delivering For Investors In 2024 (Upgrade)
- Regeneron Pharmaceuticals Inc. (REGN) American Society of Hematology 2023 Investor Conference - (Transcript)
- Regeneron eyes Wegovy combo to improve quality of weight loss
- Nevro to lay off 5% of workforce, reports Q4 worldwide revenue of $116 million
For further details see:
RBC downgrades Nevro to sector perform, cites salesforce turnaround